F2RL1 rs1529505: Understanding Your Genetic Variant
The rs1529505 variant is a single nucleotide polymorphism located in the F2RL1 gene, which encodes the proteinase-activated receptor 2 (PAR-2). Research suggests this variant may influence PAR-2 expression levels, potentially impacting inflammatory responses and specific parameters associated with asthma.
What each genotype means
Typical PAR-2 expression profile
This genotype represents the common form of the F2RL1 gene promoter. Research suggests this variant is associated with specific inflammatory parameters in asthma, though it is not definitively linked to disease severity. Please discuss any respiratory health concerns or asthma management with your clinician.
This is a common genotype found in many populations, with the C allele being frequently observed alongside the T allele.
Intermediate PAR-2 expression profile
Carrying one copy of each allele may influence the expression of the PAR-2 receptor, which plays a role in airway inflammation. Studies have identified associations between this variant and asthma-related parameters, but the clinical impact remains a subject of ongoing research. Always consult your healthcare provider regarding your specific health profile.
This heterozygous genotype is common, appearing in a significant portion of European and East Asian populations.
Alternative PAR-2 expression profile
This genotype involves the alternative allele at the F2RL1 promoter site, which has been studied for its potential role in monocyte-driven inflammation and airway responsiveness. While associations with asthma parameters have been reported, it is not a direct indicator of disease severity. Please consult with a medical professional to interpret these findings in the context of your overall health.
This genotype is observed in a substantial percentage of the population, consistent with the reported minor allele frequency of approximately 0.30 to 0.40.
What is rs1529505?
The rs1529505 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located within the F2RL1 gene. In genetic research, this variant is often referred to as a -45C/T polymorphism, indicating a substitution of the nucleotide cytosine (C) with thymine (T) at a specific position in the gene's promoter region. Because this site is located in the promoter, it is hypothesized to play a role in regulating how much of the F2RL1 gene is transcribed into messenger RNA (mRNA). By altering the regulatory landscape of the gene, rs1529505 may influence the baseline production of the PAR-2 protein in various cell types, particularly in immune cells like monocytes. Understanding this variant requires looking at how these small, individual changes in DNA sequence can ripple outward to affect cellular behavior and, ultimately, physiological traits in the human body.
The Role of the F2RL1 Gene
The F2RL1 gene provides instructions for creating the proteinase-activated receptor 2, commonly known as PAR-2. This protein is a G-protein coupled receptor found on the surface of many different cell types, including those in the airway epithelium, smooth muscle, and peripheral blood monocytes. PAR-2 acts as a sensor for specific enzymes, such as trypsin, which activate the receptor and trigger intracellular signaling pathways. These pathways are heavily involved in inflammatory processes, tissue repair, and immune responses. In the context of respiratory health, PAR-2 is known to be expressed in the airways, where its activation can contribute to airway hyperresponsiveness and the recruitment of inflammatory cells. Because F2RL1 is central to these signaling cascades, variations in its sequence—like rs1529505—are of significant interest to researchers studying how genetic differences might predispose individuals to varying levels of inflammation or sensitivity in the lungs.
Research and Associations
Scientific studies have investigated the link between rs1529505 and various inflammatory conditions. Recent research has identified an association between the 'C' allele of this SNP and levels of PAR-2 mRNA, as well as blood eosinophil counts, which are markers often monitored in allergic asthma. While some studies have explored its potential role in other conditions like osteoarthritis, the evidence regarding its impact on asthma is nuanced. Importantly, current research indicates that while rs1529505 may be associated with specific inflammatory parameters or biological markers, it has not been definitively linked to the overall severity of asthma. The evidence strength for these associations is considered moderate, meaning that while a statistical signal exists, it is not a sole determinant of health outcomes. Genetic associations are complex, and the presence of a specific genotype does not guarantee the development of any particular condition, as environmental factors and other genes also play critical roles.
What You Can Do With This Information
It is important to understand that genetic information like your rs1529505 status is for educational purposes only and should not be used for medical diagnosis or to guide treatment decisions. If you have concerns about asthma, airway health, or inflammatory symptoms, the most effective approach is to consult with a qualified healthcare professional, such as an allergist or pulmonologist. They can evaluate your clinical history, perform necessary diagnostic tests, and provide personalized medical advice. Never attempt to interpret your genetic data to adjust medications or dosages, as this can be dangerous. If you are currently taking medication for asthma or other inflammatory conditions, continue your prescribed regimen and discuss any questions about your genetic profile with your doctor or pharmacist. They are the best resources for integrating genetic insights into your overall health management plan.
How common is this variant?
The minor allele frequency for rs1529505 is approximately 0.30 to 0.40 across European and East Asian populations, indicating that the variant is relatively common.
Frequently asked questions
Is rs1529505 a cause of asthma?
No, rs1529505 is not considered a direct cause of asthma. It is a genetic variant associated with certain inflammatory markers, but asthma is a complex condition influenced by many genes and environmental factors.
Can I use this SNP to predict my asthma severity?
Current research suggests that while this variant may be associated with specific biological parameters, it has not been shown to predict the clinical severity of asthma. You should rely on clinical assessments from your doctor for managing your health.
What does the F2RL1 gene do?
The F2RL1 gene encodes the PAR-2 protein, which acts as a receptor involved in inflammatory responses and immune cell signaling. It is found in various tissues, including the airways and blood cells.
Should I change my medication based on my genotype?
No. You should never change your medication or dosage based on genetic test results without consulting your healthcare provider. Always discuss your genetic information with a doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1529505?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29